RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus

Clone Palivizumab-CP152
Catalog # CP152
Category in vivo Recombinant Antibodies
Price
Size Regular Price
1mg $ 217.00
5mg $ 843.00
25mg $ 2,942.00
50mg $ 4,229.00
100mg $ 5,910.00
About RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus

This human IgG4 S228P isotype control antibody reacts with respiratory syncytial virus and has low or no specific binding to any human sample.  The S228P mutation is included to prevent IgG4 Fab exchange. This is a recombinant human IgG4 antibody produced in CHO cells. 

RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus Specifications
IsotypeHuman IgG4, κ
Recommended Dilution BufferInVivoPure pH 7.0 Dilution Buffer
MutationsS228P
FormulationPBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin<1EU/mg (<0.001EU/μg)
Determined by LAL gel clotting assay
Purity>95%
Determined by SDS-PAGE
Sterility0.2 µm filtration
ProductionPurified from CHO cell supernatant
PurificationProtein G
Molecular Weight150 kDa
StorageThe antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Application References